GNPX
Price
$3.35
Change
-$0.00 (-0.00%)
Updated
Sep 11 closing price
Capitalization
2.79M
Intraday BUY SELL Signals
LNAI
Price
$2.38
Change
-$0.05 (-2.06%)
Updated
Sep 11 closing price
Capitalization
10.79M
Intraday BUY SELL Signals
Interact to see
Advertisement

GNPX vs LNAI

GNPX vs LNAI Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GNPX vs. LNAI commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNPX is a Hold and LNAI is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LNAI($10.8M) has a higher market cap than GNPX($2.79M). LNAI YTD gains are higher at: -66.258 vs. GNPX (-91.299). GNPX has higher annual earnings (EBITDA): -15.82M vs. LNAI (-118.57M). GNPX has more cash in the bank: 15.2M vs. LNAI (3.16M). GNPX has less debt than LNAI: GNPX (279K) vs LNAI (1.41M). LNAI has higher revenues than GNPX: LNAI (20.9K) vs GNPX (0).
GNPXLNAIGNPX / LNAI
Capitalization2.79M10.8M26%
EBITDA-15.82M-118.57M13%
Gain YTD-91.299-66.258138%
P/E Ratio0.10N/A-
Revenue020.9K-
Total Cash15.2M3.16M482%
Total Debt279K1.41M20%
FUNDAMENTALS RATINGS
GNPX vs LNAI: Fundamental Ratings
GNPX
LNAI
OUTLOOK RATING
1..100
6023
VALUATION
overvalued / fair valued / undervalued
1..100
6
Undervalued
48
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9539
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GNPX's Valuation (6) in the Pharmaceuticals Major industry is somewhat better than the same rating for LNAI (48) in the Financial Conglomerates industry. This means that GNPX’s stock grew somewhat faster than LNAI’s over the last 12 months.

GNPX's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as LNAI (100) in the Financial Conglomerates industry. This means that GNPX’s stock grew similarly to LNAI’s over the last 12 months.

GNPX's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as LNAI (100) in the Financial Conglomerates industry. This means that GNPX’s stock grew similarly to LNAI’s over the last 12 months.

LNAI's Price Growth Rating (39) in the Financial Conglomerates industry is somewhat better than the same rating for GNPX (95) in the Pharmaceuticals Major industry. This means that LNAI’s stock grew somewhat faster than GNPX’s over the last 12 months.

GNPX's P/E Growth Rating (97) in the Pharmaceuticals Major industry is in the same range as LNAI (100) in the Financial Conglomerates industry. This means that GNPX’s stock grew similarly to LNAI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GNPXLNAI
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 4 days ago
87%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (GNPX: $3.35 vs. LNAI: $2.38)
Brand notoriety: GNPX and LNAI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNPX: 23% vs. LNAI: 10%
Market capitalization -- GNPX: $2.79M vs. LNAI: $10.79M
GNPX [@Biotechnology] is valued at $2.79M. LNAI’s [@Biotechnology] market capitalization is $10.79M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNPX’s FA Score shows that 1 FA rating(s) are green while LNAI’s FA Score has 0 green FA rating(s).

  • GNPX’s FA Score: 1 green, 4 red.
  • LNAI’s FA Score: 0 green, 5 red.
According to our system of comparison, LNAI is a better buy in the long-term than GNPX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNPX’s TA Score shows that 3 TA indicator(s) are bullish while LNAI’s TA Score has 2 bullish TA indicator(s).

  • GNPX’s TA Score: 3 bullish, 2 bearish.
  • LNAI’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, GNPX is a better buy in the short-term than LNAI.

Price Growth

GNPX (@Biotechnology) experienced а -4.29% price change this week, while LNAI (@Biotechnology) price change was -0.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
GNPX
Daily Signal:
Gain/Loss:
LNAI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NTAP199.2815.68
+8.54%
NetApp
VPG65.373.65
+5.91%
Vishay Precision Group
CVSA125.091.46
+1.18%
Covista Inc.
MRDN13.71N/A
N/A
Meridian Holdings Inc.
INAB1.09-0.01
-0.91%
IN8bio Inc

LNAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, LNAI has been closely correlated with CANF. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if LNAI jumps, then CANF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LNAI
1D Price
Change %
LNAI100%
-2.26%
CANF - LNAI
72%
Closely correlated
+7.87%
APVO - LNAI
60%
Loosely correlated
+0.55%
GNPX - LNAI
56%
Loosely correlated
N/A
ICU - LNAI
55%
Loosely correlated
-3.51%
MLEC - LNAI
48%
Loosely correlated
-5.00%
More